Estrogenic and Antiestrogenic Down-regulation of Estrogen Receptor Levels: Evidence for two Different Mechanisms

References

• Moudgil V. K. Recent advance in steroid hormone action. Walter de Gruyter, Berlin 1987
   Google Scholar
• Sutherland R. L., Jordan V. C. Non-steroidal antiestrogens. Molecular pharmacology and antitumor activity. Academic Press, Sydney 1981
   Google Scholar
• Horwitz K. B., McGuire W. L. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J. biol. Chem. 1978; 253: 2223–2228
   PubMed Web of Science ®Google Scholar
• Strobl S., Kassid A., Huff K., Lippman M. E. Kinetic alterations in estrogen receptors associates with estrogen receptor processing in human breast cancer cells. Endocrinology 1984; 115: 1116–1124
   PubMed Web of Science ®Google Scholar
• Gyling M., Leclercq G. Estrogen and antiestrogen interaction with estrogen receptor of MCF-7 cells. Relationship between processing and estrogenicity. J. Steroid. Biochem. 1988; 29: 1–8
   PubMedGoogle Scholar
• Saceda M., Lippman M. E., Chambon P., Lindsey R. L., Ponglikitmongkol M., Puente M., Martin M. B. Regulation of estrogen receptor in MCF-7 cells by estradiol. Molec. Endocr. 1988; 2: 1157–1162
   PubMed Web of Science ®Google Scholar
• Read D. L., Greene G. L., Katzenellenbogen B. S. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Molec. Endocr. 1989; 3: 295–304
   PubMedGoogle Scholar
• Ree A. H., Landmark B. F., Eskild W., Levy F. O., Lahooti L. H., Jahnsen T., Aakvaag A., Hansson V. Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels. Endocrinology 1989; 124: 2577–2583
   PubMedGoogle Scholar
• Kiang D. T., Kollander R. E., Thomas T., Kennedy B. J. Up-regulation of estrogen receptors by nonsteroidal antiestrogens in human breast cancer. Cancer Res. 1989; 49: 5312–5316
   PubMed Web of Science ®Google Scholar
• Foster A. B., Jarman M., Leung O. T., McCague R., Leclercq G., Devleeschouwer N. Hydroxy derivatives of tamoxifen. J. med. Chem. 1985; 28: 1491–1497
   PubMedGoogle Scholar
• Katzenellenbogen B. S., Norman M. J., Eckert R. L., Peltz S. W., Mangel W. F. Bioactivities, estrogen receptor interactions, and plasminogen activator inducing activities of tamoxifen and hydroxytamoxifen isomers in MCF-7 human breast cancer cells. Cancer Res. 1984; 44: 112–119
   PubMed Web of Science ®Google Scholar
• Olea-Serrano N., Devleeschouwer N., Leclercq G., Heuson J. C. Assay for estrogen and progesterone receptors of breast cancer cell lines in monolayer culture. Eur. J. Cancer Clin. Oncol. 1985; 21: 965–973
   PubMedGoogle Scholar
• Madeddu L., Legros N., Devleeschouwer N., Bosman C., Piccart M., Leclercq G. Estrogen receptor status and estradiol sensitivity of MCF-7 cells in experimental growth phase. Eur. J. Cancer Clin. Oncol. 1988; 24: 385–390
   PubMedGoogle Scholar
• Jordan V. C., Gosden B. Importance of the alkylamino-ethoxy side-chain for estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus. Molec. Cell Endocr. 1982; 27: 291–306
   PubMedGoogle Scholar
• Horwitz K. B., McGuire W. L. Actinomycin D prevents nuclear processing of estrogen receptor. J. biol. Chem. 1978; 253: 6319–6322
   PubMedGoogle Scholar
• Horwitz K. B., McGuire W. L. Nuclear estrogen receptors: effect of inhibitors on processing and steady state levels. J. biol. Chem. 1980; 255: 9699–9705
   PubMedGoogle Scholar
• Aurichio F., Migliaccio A., Castoria G., Lastoria S., Rotondi A. Estrogen receptor hormone binding activity is regulated by phosphorylation-dephosphorylation of the receptor. Progress in Cancer Research and Therapy 31, F. Bresciani, R. J. B. King, M. E. Lippman, M. Namer. Raven Press, New York 1984; 49–62
   Google Scholar
• Raymoure W. J., Mc Naught R. W., Smith R. G. Reversible activation of non-steroid binding oestrogen receptor. Nature 1985; 314: 745–747
   PubMedGoogle Scholar
• Su H. D., Gonzalo J. M., Vogler W. R., Kuo J. F. Effect of tamoxifen, a non-steroidal antiestrogen, on phospholipid/-calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovary. Biochem. Pharmacol. 1985; 34: 3649–3653
   PubMed Web of Science ®Google Scholar
• Gulino A., Barrera G., Vacca A., Farina A., Ferreti C., Screpanti I., Dianzani M. U., Frati L. Calmodulin antagonism and growth inhibiting activity of triphenyl-ethylene antiestrogens in MCF-7 human breast cancer cells. Cancer Res. 1986; 46: 6274–6278
   PubMed Web of Science ®Google Scholar
• Liao S., Chang C., Kokontis J., Popovich T., Hiipakka R. A. Structure and intranuclear dynamics of androgen receptors. The Steroid/Thyroid Hormone Receptor, J. Carlstedt-Duke, H. Eriksson, J. A. Gustafsson. Birkhäuser Verlag, Basel 1989; 83–92
   Google Scholar
• Bocquel M. T., Kumar V., Stricker C., Chambon P., Gronemeyer H. The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription in both receptor and cell-specific. Nucl. Acid Res. 1989; 17: 2531–2595
   Google Scholar
• Meyer M. E., Gronemeyer H., Turcotte B., Brocquel M. T., Tasset D., Chambon P. Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 1989; 57: 433–442
   PubMed Web of Science ®Google Scholar